News

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...
Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the potential of pembrolizumab (Keytruda; Merck) to improve outcomes following head and neck ...